Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2013

01-10-2013 | Research Article

Potentially inappropriate prescribing and drug–drug interactions among elderly Chinese nursing home residents in Macao

Authors: Cheng Kin Lao, Sao Chan Ho, Ka Kit Chan, Chon Fai Tou, Henry Hoi Yee Tong, Alexandre Chan

Published in: International Journal of Clinical Pharmacy | Issue 5/2013

Login to get access

Abstract

Background The ageing of the population has become a concern all over the world, including Macao. In general, older people are more prone to adverse drug events which can result from potentially inappropriate medication (PIM) use and drug–drug interactions (DDIs). Objective This study was designed to evaluate the prevalence of PIM use and DDIs among elderly nursing home residents in Macao, and to find out the factors associated with these drug-related problems. Setting This study was conducted in the largest nursing home in Macao, with a bed capacity of 168. Method All data of this cross-sectional study were collected from medical charts and medication administration records. PIM use was determined by the screening tool of older person’s prescription (STOPP) criteria and potential DDIs were detected using the preset criteria of two compendia, Drug-Reax and Lexi-Interact. Multivariate logistic regression analysis was performed to identify the independent factors associated with each drug-related problem. Main outcome measures The proportions of elderly nursing home residents who regularly used PIMs and who were exposed to DDIs. Results A total of 114 elderly residents were eligible for PIM analysis. They consumed an average of 6.9 ± 3.1 different medications. About 46.5 % of them regularly used one or more PIMs. The prevalence of DDIs was 37.8 % among the 111 elderly residents who consumed at least two different medications. An increased number of drugs used was identified as the independent factor associated with PIM use and DDIs (p < 0.05). However, the use of STOPP-related PIMs did not appear to raise the likelihood of DDIs among the study population. Conclusion Both PIM use and DDIs are common among elderly nursing home residents in Macao. Further studies should be conducted to evaluate the clinical outcomes of pharmacist-led interventions for elderly residents in the local nursing home setting.
Literature
2.
go back to reference Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.PubMedCrossRef Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.PubMedCrossRef
3.
go back to reference Mizokami F, Koide Y, Noro T, Furuta K. Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother. 2012;10(2):123–8.PubMedCrossRef Mizokami F, Koide Y, Noro T, Furuta K. Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother. 2012;10(2):123–8.PubMedCrossRef
4.
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–17.PubMedCrossRef Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–17.PubMedCrossRef
5.
go back to reference Mamun K, Lien CT, Goh-Tan CY, Ang WS. Polypharmacy and inappropriate medication use in Singapore nursing homes. Ann Acad Med Singap. 2004;33(1):49–52.PubMed Mamun K, Lien CT, Goh-Tan CY, Ang WS. Polypharmacy and inappropriate medication use in Singapore nursing homes. Ann Acad Med Singap. 2004;33(1):49–52.PubMed
6.
go back to reference Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug–drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25(8):683–92.PubMedCrossRef Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug–drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25(8):683–92.PubMedCrossRef
7.
go back to reference Chen LL, Tangiisuran B, Shafie AA, Hassali MA. Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes. Int J Clin Pharm. 2012;34(4):596–603.PubMedCrossRef Chen LL, Tangiisuran B, Shafie AA, Hassali MA. Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes. Int J Clin Pharm. 2012;34(4):596–603.PubMedCrossRef
8.
go back to reference Ryan C, O’Mahony D, Kennedy J, Weedle P, Cottrell E, Heffernan M, et al. Potentially inappropriate prescribing in older residents in Irish nursing homes. Age Ageing. 2013;42(1):116–20.PubMedCrossRef Ryan C, O’Mahony D, Kennedy J, Weedle P, Cottrell E, Heffernan M, et al. Potentially inappropriate prescribing in older residents in Irish nursing homes. Age Ageing. 2013;42(1):116–20.PubMedCrossRef
9.
go back to reference Liao HL, Chen JT, Ma TC, Chang YS. Analysis of drug–drug interactions (DDIs) in nursing homes in Central Taiwan. Arch Gerontol Geriatr. 2008;47(1):99–107.PubMedCrossRef Liao HL, Chen JT, Ma TC, Chang YS. Analysis of drug–drug interactions (DDIs) in nursing homes in Central Taiwan. Arch Gerontol Geriatr. 2008;47(1):99–107.PubMedCrossRef
10.
go back to reference Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Junior DP, Pilger D, et al. Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012;68(12):1667–76.PubMedCrossRef Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Junior DP, Pilger D, et al. Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012;68(12):1667–76.PubMedCrossRef
11.
go back to reference Macao Yearbook Editorial Team. Macao yearbook 2012. Macao: Government Information Bureau of Macao S.A.R.; 2012. ISBN 978-99937-56-25-5. Macao Yearbook Editorial Team. Macao yearbook 2012. Macao: Government Information Bureau of Macao S.A.R.; 2012. ISBN 978-99937-56-25-5.
12.
go back to reference Social Welfare Bureau of Macao S.A.R. Social service facilities—home for the elderly [Internet]. Macao: Social Welfare Bureau of Macao S.A.R.; cited 17 May 2012]. Available from http://www.ias.gov.mo/en/. Social Welfare Bureau of Macao S.A.R. Social service facilities—home for the elderly [Internet]. Macao: Social Welfare Bureau of Macao S.A.R.; cited 17 May 2012]. Available from http://​www.​ias.​gov.​mo/​en/​.
13.
go back to reference Levenson SA, Saffel DA. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success. J Am Med Dir Assoc. 2007;8(1):55–64.PubMedCrossRef Levenson SA, Saffel DA. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success. J Am Med Dir Assoc. 2007;8(1):55–64.PubMedCrossRef
14.
go back to reference World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs) [Internet]. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2011. [Updated 2011; cited 6 Dec 2012]. Available from http://www.whocc.no/atc_ddd_index/. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs) [Internet]. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2011. [Updated 2011; cited 6 Dec 2012]. Available from http://​www.​whocc.​no/​atc_​ddd_​index/​.
15.
go back to reference Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.PubMedCrossRef Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.PubMedCrossRef
16.
go back to reference Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, et al. Inter-rater reliability of STOPP (screening tool of older persons’ prescriptions) and START (screening tool to alert doctors to right treatment) criteria amongst physicians in six European countries. Age Ageing. 2009;38(5):603–6.PubMedCrossRef Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, et al. Inter-rater reliability of STOPP (screening tool of older persons’ prescriptions) and START (screening tool to alert doctors to right treatment) criteria amongst physicians in six European countries. Age Ageing. 2009;38(5):603–6.PubMedCrossRef
17.
go back to reference Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother. 2009;43(7):1239–44.PubMedCrossRef Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother. 2009;43(7):1239–44.PubMedCrossRef
20.
go back to reference Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Evaluation of frequently used drug interaction screening programs. Pharm World Sci. 2008;30(4):367–74.PubMedCrossRef Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Evaluation of frequently used drug interaction screening programs. Pharm World Sci. 2008;30(4):367–74.PubMedCrossRef
21.
go back to reference Wong CM, Ko Y, Chan A. Clinically significant drug–drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Ann Pharmacother. 2008;42(12):1737–48.PubMedCrossRef Wong CM, Ko Y, Chan A. Clinically significant drug–drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Ann Pharmacother. 2008;42(12):1737–48.PubMedCrossRef
22.
go back to reference Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49(2):200–9.PubMedCrossRef Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49(2):200–9.PubMedCrossRef
23.
go back to reference van der Hooft CS, Schoofs MW, Ziere G, Hofman A, Pols HA, Sturkenboom MC, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol. 2008;66(2):276–82.PubMedCrossRef van der Hooft CS, Schoofs MW, Ziere G, Hofman A, Pols HA, Sturkenboom MC, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol. 2008;66(2):276–82.PubMedCrossRef
24.
go back to reference Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–37.PubMedCrossRef Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–37.PubMedCrossRef
25.
go back to reference Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007;63(6):709–14.PubMedCrossRef Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007;63(6):709–14.PubMedCrossRef
26.
go back to reference Rodriguez-Terol A, Caraballo MO, Palma D, Santos-Ramos B, Molina T, Desongles T, et al. Quality of interaction database management systems. Farm Hosp. 2009;33(3):134–46.PubMedCrossRef Rodriguez-Terol A, Caraballo MO, Palma D, Santos-Ramos B, Molina T, Desongles T, et al. Quality of interaction database management systems. Farm Hosp. 2009;33(3):134–46.PubMedCrossRef
27.
go back to reference Secoli SR, Figueras A, Lebrao ML, de Lima FD, Santos JL. Risk of potential drug–drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs Aging. 2010;27(9):759–70.PubMedCrossRef Secoli SR, Figueras A, Lebrao ML, de Lima FD, Santos JL. Risk of potential drug–drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs Aging. 2010;27(9):759–70.PubMedCrossRef
28.
go back to reference Carter BL, Lund BC, Hayase N, Chrischilles E. The extent of potential antihypertensive drug interactions in a Medicaid population. Am J Hypertens. 2002;15(11):953–7.PubMedCrossRef Carter BL, Lund BC, Hayase N, Chrischilles E. The extent of potential antihypertensive drug interactions in a Medicaid population. Am J Hypertens. 2002;15(11):953–7.PubMedCrossRef
29.
go back to reference Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities. BMC Geriatr. 2006;6:1.PubMedCrossRef Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities. BMC Geriatr. 2006;6:1.PubMedCrossRef
30.
go back to reference Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther. 2011;36(1):33–44.PubMedCrossRef Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther. 2011;36(1):33–44.PubMedCrossRef
31.
go back to reference Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother. 2006;4(2):134–43.PubMedCrossRef Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother. 2006;4(2):134–43.PubMedCrossRef
32.
go back to reference Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34(4):377–86.PubMedCrossRef Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34(4):377–86.PubMedCrossRef
33.
go back to reference Gallagher P, O’Mahony D. STOPP (screening tool of older persons’ potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–9.PubMedCrossRef Gallagher P, O’Mahony D. STOPP (screening tool of older persons’ potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–9.PubMedCrossRef
34.
go back to reference Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33(3):549–57.PubMedCrossRef Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33(3):549–57.PubMedCrossRef
35.
go back to reference Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157(18):2089–96.PubMedCrossRef Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157(18):2089–96.PubMedCrossRef
36.
go back to reference Halvorsen KH, Stensland P, Granas AG. A qualitative study of physicians’ and nurses’ experiences of multidisciplinary collaboration with pharmacists participating at case conferences. Int J Pharm Pract. 2011;19(5):350–7.PubMedCrossRef Halvorsen KH, Stensland P, Granas AG. A qualitative study of physicians’ and nurses’ experiences of multidisciplinary collaboration with pharmacists participating at case conferences. Int J Pharm Pract. 2011;19(5):350–7.PubMedCrossRef
37.
go back to reference Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.PubMedCrossRef Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.PubMedCrossRef
38.
go back to reference Page RL II, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.PubMedCrossRef Page RL II, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.PubMedCrossRef
Metadata
Title
Potentially inappropriate prescribing and drug–drug interactions among elderly Chinese nursing home residents in Macao
Authors
Cheng Kin Lao
Sao Chan Ho
Ka Kit Chan
Chon Fai Tou
Henry Hoi Yee Tong
Alexandre Chan
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9811-y

Other articles of this Issue 5/2013

International Journal of Clinical Pharmacy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.